Category Archives: (Sandbox Syndication Account) Health News (Master Feed)
U.S. FDA approves Amgen’s biosimilar version of J&J’s psoriasis drug
(Reuters) -The U.S. Food and Drug Administration on Tuesday approved Amgen's biosimilar version of Johnson & Johnson's blockbuster psoriasis treatment, Stelara, for multiple inflammatory diseases. Des...
Oct 31, 2023
FDA panel says Vertex/CRISPR to assess safety risks of gene therapy in follow-up study
(Reuters) - A panel of advisers to the U.S. health regulator said on Tuesday Vertex Pharmaceuticals and CRISPR Therapeutics could assess potential safety risks of their sickle cell disease gene therap...
Oct 31, 2023
Waystar delays IPO until December or 2024 – Wall Street Journal
(Reuters) - Healthcare software company Waystar, which was set to launch its initial public offering roadshow to pitch investors this week, has now delayed it until December at the earliest, the Wall ...
Oct 31, 2023
Cytokinetics exploring options after receiving takeover interest – Bloomberg News
(Reuters) - Heart diseases-focused drug developer Cytokinetics is weighing options after receiving takeover interest, Bloomberg News reported on Tuesday, citing people familiar with the matter. The co...
Oct 31, 2023
Drugmaker Incyte’s quarterly profit beats on lower costs
(Reuters) - Incyte reported a third-quarter profit on Tuesday that beat analysts' estimates as lower costs helped offset weak sales of its blood cancer drug Jakafi. The Delaware-based company has been...
Oct 31, 2023
Ametek raises profit outlook, buys Paragon Medical in $1.9 billion deal
(Reuters) - Ametek, which makes electronic instruments, raised its full-year forecast on Tuesday and announced its fifth and sixth acquisitions for 2023 as it expands into different markets and drives...
Oct 31, 2023
Sarepta shares slump as muscle disorder therapy fails to meet key trial goal
(Reuters) - Sarepta Therapeutics shares fell over 42% in premarket trading on Tuesday, after its gene therapy for a progressive muscle-wasting disorder failed to meet the main goal in a trial that was...
Oct 31, 2023
GSK signs $1 billion deal for exclusive license to J&J’s hepatitis B therapy
(Reuters) - British drugmaker GSK said on Tuesday it had signed a $1 billion agreement with Johnson & Johnson-owned Janssen for exclusive rights to further develop and commercialize the U.S.-based com...
Oct 31, 2023
GE HealthCare beats quarterly profit estimates on imaging device demand
(Reuters) - GE HealthCare Technologies Inc on Tuesday beat Wall Street expectations for third-quarter profit as a continued recovery in demand for surgical procedures boosted sales of its medical devi...
Oct 31, 2023
WHO warns of ‘imminent public health catastrophe’ in Gaza
GENEVA (Reuters) - A "public health catastrophe" is imminent in Gaza, the World Health Organization (WHO) said on Tuesday, amid overcrowding, mass displacement and damage to water and sanitation infra...
Oct 31, 2023
